Entrepreneur
Discover the latest developments in femtech investment
Femtech World explores the latest investment developments in female health.
Major boost for women’s health research in Wales, UK
The Women’s Health Research Wales centre for excellence will benefit from a £3m investment from Health and Care Research Wales, supported by the Welsh Government, on top of £750,000 available for other dedicated women’s health research projects.
The funding boost represents a significant commitment to address health inequalities and shape future services for women, as set out in the women’s health plan for Wales.
The Women’s Health Network, part of the NHS Executive, will now work with Health and Care Research Wales and the academic community to improve the women specific health evidence available in Wales.
Australia to see AUD$573m investment in women’s health
Australia will see a huge funding boost to the tune of AUD$57m to support women’s health.
The funding will enable improved Medicare payments and subsidies for contraceptive pills and menopause treatments through the country’s pharmaceutical benefits scheme (PBS). The move marks the first PBS listing for new oral contraceptive pills in more than 30 years, and the first PBS listing for new menopausal hormone therapies in over 20 years.
Additionally, the funding will see the opening of 11 new clinics for the treatment of endometriosis and pelvic pain.
The five-year investment by the Albanese Labor Government has been informed by extensive consultation with women, healthcare providers, advocacy groups, the work of the National Women’s Health Advisory Council, and the findings of two separate Senate inquiries.
Femasy’s products gain UK regulatory approval
Biomedical company Femasys has received UK regulatory approval for three of its products: the FemaSeed Intratubal Insemination device, FemVue for tubal evaluation, and FemCerv for cervical cancer detection.
The Medicines & Healthcare products Regulatory Agency (MHRA) has given the green light to these devices, which are already approved in the US, Europe, Canada, and Israel.
FemaSeed is a novel approach to artificial insemination, designed to deliver sperm directly to the fallopian tube, which is the natural site of conception. This method is seen as a safe, accessible, and cost-effective first-line option for infertility treatment, offering an alternative to traditional intrauterine insemination (IUI) and in vitro fertilization (IVF).
FemVue is an FDA-cleared product for real-time evaluation of the fallopian tubes using ultrasound, employing a natural saline and air contrast. It serves as a companion diagnostic tool, especially relevant for FemaSeed treatments that require at least one open fallopian tube.
FemCerv is the only FDA-cleared device specifically designed to collect a comprehensive and uncontaminated sample for cervical cancer detection in a pain-free office procedure.
Ovum Raises US$1.7M to accelerate AI-powered women’s health
Women’s health company Ovum has raised US$1.7m to advance its AI-powered app to help close the gender data gap.
The app has been designed to help women manage their menstrual cycle and pain conditions related to female health such as endometriosis.
According to reports, the company is aiming to build a women-specific AI dataset to help improve diagnosis and treatments for women.
US$4m for at-home maternal platform
Virtual maternal care company SimpliFed has raised US$4m in funding that will help implement and scale SimpliFed’s care delivery from a point solution to a complete maternal care technology platform with its newly updated mOS (Maternal Health Operating System).
According to the company, SimpliFed’s longitudinal model sees patients through the journey of pregnancy and postpartum time with supportive, consistent touch points centered around baby feeding.
The company will now be growing its care offering to include virtual, high-risk monitoring and mental health screening with attention to high-quality maternal mental healthcare.
Reimbursement for endometriosis saliva test
France-based biotech company Ziwig has announced the fast-track reimbursement of Ziwig Endotest – a saliva diagnostic test for endometriosis – for 25 000 patients across 80 medical centers in France thanks to the recent Innovation Funding decree.
The test is a biological test for practitioners and patients that can improve diagnosis times, detect complex and early stage cases sooner, provide an alternative to invasive procedures;
and, improve fertility preservation through early diagnosis.
CAD$4.1m to support menopause care in Canada
Women’s digital health startup, Coral, has announced the completion of a CAD$4.1m funding round and the launch of its virtual care platform. The funding will enable Coral to deliver integrated, personalised solutions for women navigating perimenopause and menopause in Canada.
Coral’s virtual platform includes detailed, at-home health assessments including blood testing, body composition scan analysis, and in-depth health questionnaires to get a detailed and complete picture of each woman’s health status; personalised care plans that include individualised health guides; and, integrated support that includes preventive team-based medical care, prescriptions, and lifestyle guidance to optimise nutrition, fitness, and mental health.
Daré Bioscience announces funding award
Daré Bioscience has announced it has received a Notice of Award of a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to fund non-clinical activities to support the development of DARE-HPV – an investigational treatment for HPV-related cervical disease.
The NIAID funding award is supplemental to the company’s previous US$10m award and will support non-clinical development activities that are not being conducted under that award.
Daré is eligible to receive up to a total of approximately US$2m in grant funding for its DARE-HPV programme based on the grant application it submitted. A grant in the amount of US$1m has been awarded for the 2025 project year, and another US$1m has been recommended for a subsequent project year, subject to the availability of funds and satisfactory progress of the project, as determined by NIAID.
You have until Friday to nominate your femtech company of the year.
The award is one of 10 featuring at Femtech World’s third annual awards event, which attracts entries from across the UK, EU and Europe.
The Company of the Year Award is for companies that have demonstrated exceptional leadership in tackling women’s health needs through groundbreaking products, services or platforms that are shaping the future of global femtech.
If your company is driving innovation, impact and growth in this space, this award was made for you.
About the sponsor: Femovate
The category is backed by Femovate, the global femtech incubator using design to fuel innovation across every stage of a woman’s health journey, from proactive prevention through to personalised treatment.
Femovate has invested over US$2 million in design capital, working side-by-side with founding teams to bring market-ready solutions to life.
The startups it supports have collectively raised US$120 million, launched 30 products, and secured seven FDA clearances.
Why enter?
The Femtech World Awards are free to enter.
Winners and shortlisted companies receive extensive coverage across all Femtech World platforms.
Winners will also receive a trophy and the opportunity to be featured in an interview for the publication.
Find out more about the Femtech World Award and enter here by 4pm BST on Friday 17.
By Chaitra Vedullapalli, founder and president, Women in Cloud
Today’s leaders are carrying more than responsibilities.
They are carrying caregiving roles, financial pressures, legal complexities, and the quiet emotional weight of sustaining performance in unpredictable times.
And yet, most leadership forums still focus on productivity, growth, and scale, rarely addressing the human systems that enable sustained leadership.
At Women in Cloud, we believe the next generation of leadership will not be defined by endurance alone, but by discipline, preparation, and self-respect.
That is why we are proud to announce the #WICxWellness Summit 2026: The Disciplined Advantage.
This is a wellness summit focused on leadership preparedness.
Why This Summit Matters Now
Across our global community, a clear pattern has emerged.
- More professionals and executives are quietly navigating:
- Life-threatening health crises, personally or within their families
- Financial stress caused by medical, caregiving, or business shocks
- Legal and healthcare decisions with long-term consequences
- Career interruptions due to caregiving responsibilities
- Chronic exhaustion, grief, and emotional isolation
These experiences are widespread, yet rarely discussed in executive settings.
#WICxWellness 2026 brings these realities into the open with compassion, clarity, and practical guidance, so leaders can prepare, adapt, and continue forward without breaking.
This is wellness as a leadership discipline.
What We Will Explore
This year’s summit is designed to provide grounded, immediately applicable insights for founders, executives, and senior leaders.
Executive Function Under Chronic Stress
Keynote with Jennifer Brown
Focus Areas:
- Understand how chronic stress alters judgment, focus, and emotional regulation
- Identify early warning signs of cognitive overload in leadership roles
- Adaptability as a Cognitive Anchor: Navigating rapid change without compromising decision-making.
- Resilience Through Connection: Building human-centric teams to mitigate the stress of uncertainty.
- Navigating Change with Emotional Intelligence: Regulating stress responses to maintain clarity and empathy.
- Systemic Agility in High-Pressure Environments: Creating foundations of psychological safety that protect organizational function
Labs That Matter (And What to Do With Them)
Fireside Chat with Chelsey Galipeau and Chaitra Vedullapalli
Focus Areas:
- Which health tests are worth the time and investment
- Interpreting results without panic
- Preventive strategies for executive longevity
- Avoiding unnecessary medical spending
Caretaking Without Collapse
Panel With Karen Fassio, Anca Platon Trifan, Scilla Andreen, Clara Schroeder, Sheena Yap Chan
Focus Areas:
- Managing family and professional demands without burnout
- Setting humane boundaries
- Building sustainable support systems
- Ending silent sacrifice in leadership
Food as a Stability System (Not a Diet)
Fireside Chat with Nancy Watt and Meagan T. Copelin
Focus Areas:
- Nutrition for sustained energy and clarity
- Blood sugar and decision-making
- Realistic eating during travel and stress
- Food as operational resilience
Autoimmunity, Hormones & Cardiac Risk in Real Life
Fireside Chat with Dr. Linda Bing
Focus Areas:
- Managing invisible health risks
- Hormonal transitions and stamina
- Flare prevention at work
- Energy mapping for leadership performance
A Different Kind of Leadership Conversation
At Women in Cloud, we have learned something fundamental:
Performance is visible. Discipline is invisible.
Yet discipline determines whether leaders can serve, build, and lead over decades, not just quarters.
The Disciplined Advantage is about building that resilience intentionally.
Through science, lived experience, and practical frameworks, this summit equips leaders to:
- Anticipate strain instead of reacting to a crisis Design sustainable work rhythms
- Protect cognitive and emotional capital
- Lead from grounded strength
This is leadership infrastructure for the next decade.
Join Us
If you are a founder, executive, technologist, or senior professional navigating complexity and determined to lead well without sacrificing your health, clarity, or longevity, this summit is for you.
The #WICxWellness Summit 2026 is where performance meets preservation. Where ambition meets sustainability. Where leadership becomes truly durable.
We look forward to welcoming you. The Disciplined Advantage begins here.
Secure your spot: https://www.eventbrite.com/e/wicxwellness-summit-2026-tickets-1981616382945?aff=oddtdtcreator
Femtech World is continuing the search for a company to be crowned Startup of the Year.
The award is one of 10 to feature at the third annual Femtech World Awards.
The Startup of the Year Award celebrates an early-stage company making a bold impact in women’s health through innovation, vision and execution.
The winning startup will have demonstrated strong potential to transform care, accessibility, or awareness in women’s health with a scalable solution.
Consideration will be given to innovation, market traction, inclusivity, impact and the ability to address unmet needs.
The award is sponsored by Future Fertility.
The company is transforming fertility care with AI-powered solutions that close critical information gaps along the IVF journey.
Its clinically validated, non-invasive tools analyse oocyte images to predict each egg’s reproductive potential, supporting decision-making across key pathways: VIOLET™ for egg freezing, MAGENTA™ for IVF-ICSI, and ROSE™ for donor programmes and egg banks.
These reports deliver personalised insights into egg quality and ploidy potential, empowering patients and clinicians to make more informed decisions regarding next steps.
Today, Future Fertility’s technology is used in more than 300 clinics across 35+ countries.
Developed with the world’s largest oocyte image dataset linked to reproductive outcomes, Future Fertility’s AI models generate quality scores that not only guide treatment planning and manage expectations, but also serve as objective, actionable KPIs for labs—driving improved outcomes and transparency in fertility care worldwide.
The awards are free to enter, with winners receiving a trophy and an interview with Femtech World.
Find out more about the awards and enter for free here.
Entrepreneur6 days agoFuture Fertility raises Series A financing to scale AI tools redefining fertility care worldwide
Entrepreneur4 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy4 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
News4 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Diagnosis2 weeks agoFuture Fertility partners with Japan’s leading IVF provider, Kato Ladies Clinic
Mental health1 week agoLifting weights shows mental health and cognitive benefits in older women, study finds
Menopause2 weeks agoMore research needed to understand link between brain fog and menopause, expert says
News4 weeks agoCopper coil vs Mirena: Which is right for you?